Abstract:Abstract Background Breast cancer is the most frequently diagnosed malignancy among women and the second leading cause of cancer death worldwide. Among which nuclear estrogen receptor (nER) negative breast cancer is always with much poor prognosis. Recently, membrane G protein coupled estrogen receptor (GPER), a newly recognized estrogen receptor has been documented to take essential part in the development and treatment of breast cancer. The present study was designed to investigate the anti nER negative breast cancer effect of cryptotanshinone (CPT), an important active compound of traditional Chinese medicine Danshen and its possible molecular pathway. Methods The following in vitro tests were performed in nER negative but GPER positive breast cancer SKBR-3 cells. The effect of CPT on cell proliferation rate and cell cycle distribution was evaluated by MTT cell viability test and flow cytometry assay respectively. The role of PI3K/AKT pathway and the mediated function of GPER were tested by western blot and immunofluorescence. Technique of gene silence and the specific GPER agonist G-1 and antagonist G-15 were employed in the experiments to further verify the function of GPER in mediating the anticancer role of CPT. Results The results showed that proliferation of SKBR-3 cells could be blocked by CPT in a time and dose dependent manner. CPT could also exert antiproliferative activities by arresting cell cycle progression in G1 phase and down regulating the expression level of cyclin A, cyclin B, cyclin D and cyclin-dependent kinase 2 (CDK2). The antiproliferative effect of CPT was further enhanced by G-1 and attenuated by G-15. Results of western blot and immunofluorescence showed that expression of PI3K and p-AKT could be downregulated by CPT and such effects were mediated by GPER which were further demonstrated by gene silence test. Conclusion The current study showed that the antiproliferative action of CPT on SKBR-3 cells was realized by inhibition of GPER mediated PI3K/AKT pathway. These findings provide further validation of GPER serving as useful therapeutic target.

Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway

Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation

3'-Desmethylarctigenin induces G2/M cell cycle arrest and apoptosis through reactive oxygen species generation in hepatocarcinoma cells.

Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway.

3′‐Desmethylarctigenin Induces G2/M Cell Cycle Arrest and Apoptosis Through Reactive Oxygen Species Generation in Hepatocarcinoma Cells

Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer

Arctigenin Inhibits Glioblastoma Proliferation Through the AKT/mTOR Pathway and Induces Autophagy

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.

Preclinical Evidence that Arctigenin Effectively and Selectively Targets Clear Cell Renal Cell Carcinoma Via Suppressing EGFR and RhoA

Arctigenin upregulates apoptosis through the AKT/MTOR pathway, inhibiting the proliferation of glioma

Arctigenin Attenuates Tumor Metastasis Through Inhibiting Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma Via Suppressing GSK3β-Dependent Wnt/β-Catenin Signaling Pathway in Vivo and in Vitro

Arctigenin Induces Apoptosis in Colon Cancer Cells Through ROS/p38MAPK Pathway.

Arctigenin Triggers Apoptosis and Autophagy Via PI3K/Akt/mTOR Inhibition in PC-3M Cells.

Arctigenin Induces Apoptosis in Melanoma Cells by Reducing the Expression of BCL-2 and VEGF

The Β-Glucan from Lentinus Edodes Suppresses Cell Proliferation and Promotes Apoptosis in Estrogen Receptor Positive Breast Cancers.

Genistein Inhibits Proliferation Similarly in Estrogen Receptor-Positive and Negative Human Breast Carcinoma Cell Lines Characterized by P21WAF1/CIP1 Induction, G2/M Arrest, and Apoptosis.

Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells

Estrogen Receptor-Α36 is Involved in Icaritin Induced Growth Inhibition of Triple-Negative Breast Cancer Cells